N@N

Colin Rusch Maintained (TSLA) at Buy on, Apr 27th, 2021

^{Published on 2024-10-27 16:23:11 - WOPRAI, Colin Rusch}
 

Colin has made no other calls on TSLA in the last 4 months.

There are 15 other peers that have a rating on TSLA. Out of the 15 peers that are also analyzing TSLA, 6 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Philippe Houchols of "Jefferies" Maintained at Hold with Decreased Target to $233 on, Monday, March 29th, 2021
• Patrick Hummel of "UBS" Maintained at Hold with Increased Target to $730 on, Wednesday, March 3rd, 2021
• Joseph Osha of "JMP Securities" Downgraded from Buy to Hold on, Thursday, January 28th, 2021
• Joseph Spak of "RBC Capital" Maintained at Hold with Increased Target to $242 on, Thursday, January 28th, 2021
• Craig Irwin of "Roth Capital" Maintained at Hold and Held Target at $50 on, Thursday, January 28th, 2021
• Chris McNally of "Evercore ISI Group" Upgraded from Sell to Hold and Held Target at $217 on, Friday, January 8th, 2021

These are the ratings of the 9 analyists that currently disagree with Colin

• Adam Jonas of "Morgan Stanley" Maintained at Buy with Increased Target to $300 on, Friday, April 23rd, 2021
• Vijay Rakesh of "Mizuho" Maintained at Strong Buy with Increased Target to $273 on, Tuesday, April 20th, 2021
• Ryan Brinkman of "JP Morgan" Maintained at Sell with Increased Target to $52 on, Monday, April 5th, 2021
• Daniel Ives of "Wedbush" Upgraded from Hold to Buy and Increased Target to $333 on, Monday, April 5th, 2021
• Pierre Ferragu of "New Street Research" Upgraded from Hold to Strong Buy and Held Target at $300 on, Tuesday, March 9th, 2021
• Alexander Potter of "Piper Sandler" Maintained at Buy with Increased Target to $400 on, Monday, February 1st, 2021
• Emmanuel Rosner of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $300 on, Thursday, January 28th, 2021
• Ben Kallo of "Baird" Maintained at Buy with Increased Target to $243 on, Monday, January 25th, 2021
• Stuart Pearson of "Exane BNP Paribas" Downgraded from Hold to Sell and Decreased Target to $113 on, Tuesday, January 5th, 2021